(Q35094247)

6 August 2017

1 reference

title

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. (English)

1 reference

6 August 2017

0 references

9

Jean-Louis Vincent

1 reference

6 August 2017

6

Deborah Cook

1 reference

6 August 2017

8

Steven M Opal

1 reference

6 August 2017

Mitchell M Levy

1

1 reference

6 August 2017

Mitchell P Fink

2

1 reference

6 August 2017

John C Marshall

3

1 reference

6 August 2017

Edward Abraham

4

1 reference

6 August 2017

Derek Angus

5

1 reference

6 August 2017

Jonathan Cohen

7

1 reference

6 August 2017

Graham Ramsay

10

1 reference

6 August 2017

International Sepsis Definitions Conference

11

1 reference

6 August 2017

28 March 2003

1 reference

6 August 2017

Intensive Care Medicine

1 reference

6 August 2017

29

1 reference

6 August 2017

530-538

1 reference

6 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-003-1662-x

6 August 2017

0 references

cites work

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

1 reference

12 December 2020

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

12 December 2020

Epidemiology of sepsis and multiple organ dysfunction syndrome in children

1 reference

12 December 2020

Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock

1 reference

12 December 2020

Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T

1 reference

12 December 2020

Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients

1 reference

12 December 2020

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

1 reference

12 December 2020

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels

1 reference

12 December 2020

Dear SIRS, I'm sorry to say that I don't like you

1 reference

12 December 2020

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

12 December 2020

History and international developments in cancer staging

1 reference

12 December 2020

Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction

1 reference

12 December 2020

Multiple organ dysfunction: baseline and serial component scores

1 reference

12 December 2020

SIRS and MODS: what is their relevance to the science and practice of intensive care?

1 reference

12 December 2020

Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis

1 reference

12 December 2020

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

12 December 2020

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia

1 reference

12 December 2020

Development of a pediatric multiple organ dysfunction score: use of two strategies.

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study

1 reference

12 December 2020

Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery

1 reference

12 December 2020

Time course of immunological markers in patients with the systemic inflammatory response syndrome: evaluation of sCD14, sVCAM-1, sELAM-1, MIP-1alpha and TGF-beta2

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

12 December 2020

Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction

1 reference

12 December 2020

Serial evaluation of the SOFA score to predict outcome in critically ill patients

1 reference

12 December 2020

Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome

1 reference

12 December 2020

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

1 reference

12 December 2020

Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

10.1007/S00134-003-1662-X

Identifiers

DOI

1 reference

6 August 2017

1 reference